Insider Trading & Ownership - Kunin Audrey

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kunin Audrey
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-06
Sale
2022-12-07
4:55 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
1$1.81$20
(Indirect)
View
2022-11-21
Sale(A)
2022-12-05
5:30 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
5,960$2.1049$12,5451
(Indirect)
View
2022-11-21
Sale
2022-11-23
4:16 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
5,960$2.1049$12,5450
(Indirect)
View
2022-09-14
Sale
2022-09-16
6:24 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
291,368$0.1582$46,094208,632
(Indirect)
View
2021-12-03
Purchase
2021-12-07
5:43 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
101,650$0.4625$47,013500,000
(Indirect)
View
2021-12-02
Purchase
2021-12-06
4:31 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
262,369$0.476$124,888398,350
(Indirect)
View
2021-12-01
Purchase
2021-12-03
4:30 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
14,848$0.49$7,276135,981
(Indirect)
View
2021-11-30
Purchase
2021-12-02
4:30 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
30,000$0.46$13,800121,133
(Indirect)
View
2021-11-22
Purchase
2021-11-24
4:46 pm
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
91,133$0.45942$41,86891,133
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2021-11-17
8:15 pm
N/A
N/A
NovaBay Pharmaceuticals Inc.NBYKunin Audrey
Chief Product Officer
0$0150,000
(Direct)
View
(A) Indicate amendment filing.